V. Cellular basis of action of GI peptides. Recent studies demonstrate a number of hormones and neurotransmitters that alter cell function by interacting with G-protein-coupled hepta- helical receptors can cause tyrosine phosphorylation similar to a number of growth factors, and this pathway may be involved in mediating these agent's growth effects. We examined both the ability of neuromedin B in C6 glioblastoma cells and NMB-R transfected cells and the ability of cholecystokinin (CCK) in rat pancreatic acini to cause tyrosine phosphorylation of p125 focal adhesion kinase (p125FAK), which plays an important role in mediating the growth effects of a number of neuropeptides. NMB cause rapid tyrosine phosphorylation of p125FAK in both cell types. The activation was not dependent on PKC activation or changes in [Ca2+]; because it was not altered by thapsigargin or PKC inhibitors. Cellular microfilaments but not microtubules were needed for p125FAK phosphorylation. Small GTP binding proteins mediated 50% of the NMB-mediated p125FAK phosphorylation because it was partially inhibited by clostridium botulinum C-3 toxin. CCK caused rapid p125FAK and paxillin phosphorylation through CCK/A receptors and the phosphorylation was mediated by activation of both high and low CCK affinity receptors. P125FAK phosphorylation by CCK did not require PKC or PLC activation. These studies show that activation of both the NMB-R and CCK/A-R can cause tyrosine phosphorylation of p125FAK, which may be an important mediator of the growth effects of these peptides.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK053101-08
Application #
2573666
Study Section
Special Emphasis Panel (DDB)
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Gonzalez, Nieves; Nakagawa, Tomoo; Mantey, Samuel A et al. (2009) Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor. J Pharmacol Exp Ther 331:265-76
González, Nieves; Mantey, Samuel A; Pradhan, Tapas K et al. (2009) Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. Peptides 30:1473-86
Gonzalez, Nieves; Moody, Terry W; Igarashi, Hisato et al. (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15:58-64
Jensen, R T; Battey, J F; Spindel, E R et al. (2008) International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42
Gonzalez, Nieves; Hocart, Simon J; Portal-Nunez, Sergio et al. (2008) Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor. J Pharmacol Exp Ther 324:463-74
Berna, Marc J; Jensen, Robert T (2007) Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem 7:1211-31
Moody, Terry W; Mantey, Samuel A; Fuselier, Joseph A et al. (2007) Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Peptides 28:1883-90
Berna, Marc J; Tapia, Jose A; Sancho, Veronica et al. (2007) Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential. Curr Opin Pharmacol 7:583-92
Berna, Marc J; Hoffmann, K Martin; Tapia, Jose A et al. (2007) CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways. Biochim Biophys Acta 1773:483-501
Corleto, V D; Severi, C; Romano, G et al. (2006) Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil 18:217-25

Showing the most recent 10 out of 27 publications